Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2010; 16(46): 5779-5789
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5779
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5779
Figure 3 Blockades of type I insulin-like growth factor receptor reduce tumor progression through several interruptions of type I insulin-like growth factor receptor-mediated functions, including type I insulin-like growth factor receptor/matrilysin positive feedback system.
IGF-IR: Type I insulin-like growth factor receptor; IGFBPs: IGF binding proteins.
- Citation: Adachi Y, Yamamoto H, Ohashi H, Endo T, Carbone DP, Imai K, Shinomura Y. A candidate targeting molecule of insulin-like growth factor-I receptor for gastrointestinal cancers. World J Gastroenterol 2010; 16(46): 5779-5789
- URL: https://www.wjgnet.com/1007-9327/full/v16/i46/5779.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i46.5779